{
    "Trade/Device Name(s)": [
        "Healgen\u00ae Accurate Oral Fluid Drug Test",
        "Healgen\u00ae Accurate Oral Fluid Drug Test COT"
    ],
    "Submitter Information": "Healgen Scientific LLC",
    "510(k) Number": "K223162",
    "Predicate Device Reference 510(k) Number(s)": [
        "K141320",
        "K033601"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "LDJ",
        "MKU"
    ],
    "Summary Letter Date": "February 12, 2023",
    "Summary Letter Received Date": "February 13, 2023",
    "Submission Date": "March 16, 2023",
    "Regulation Number(s)": [
        "21 CFR 862.3870",
        "21 CFR 862.3220"
    ],
    "Regulation Name(s)": [
        "Cannabinoid Test System",
        "Cotinine Test System"
    ],
    "Analyte Class(es)": [
        "toxicology"
    ],
    "Analyte(s)": [
        "Marijuana (THC)",
        "Cotinine"
    ],
    "Specimen Type(s)": [
        "Oral fluid"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [],
    "Method(s)/Technology(ies)": [
        "Lateral flow immunochromatographic assay",
        "Competitive binding immunoassay"
    ],
    "Methodologies": [
        "Immunochromatographic assay",
        "Lateral flow",
        "Competitive binding"
    ],
    "Submission Type(s)": [
        "Assay"
    ],
    "Document Summary": "FDA 510(k) summary for Healgen Accurate Oral Fluid Drug Test and COT, lateral flow assay for qualitative detection of THC and cotinine in oral fluid.",
    "Indications for Use Summary": "For qualitative and simultaneous detection of Marijuana (THC) and Cotinine in human oral fluid at specified cutoff concentrations; provides preliminary results requiring confirmatory laboratory testing.",
    "fda_folder": "Toxicology"
}